Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 18:2022:9356807.
doi: 10.1155/2022/9356807. eCollection 2022.

The Exosome Journey: From Biogenesis to Regulation and Function in Cancers

Affiliations
Review

The Exosome Journey: From Biogenesis to Regulation and Function in Cancers

Yuan Li et al. J Oncol. .

Abstract

Exosomes are a type of small endosomal-derived vesicles ranging from 30 to 150 nm, which can serve as functional mediators in cell-to-cell communication and various physiological and pathological processes. In recent years, exosomes have emerged as crucial mediators of intracellular communication among tumor cells, immune cells, and stromal cells, which can shuttle bioactive molecules, such as proteins, lipids, RNA, and DNA. Exosomes exhibit the high bioavailability, biological stability, targeting specificity, low toxicity, and immune characteristics, suggesting their potentials in the diagnosis and treatment of cancers. They can be applied as an effective tool in the diagnostics, therapeutics, and drug delivery in cancers. This review summarizes the regulation and functions of exosomes in various cancers to augment our understanding of exosomes, which paves the way for parallel advancements in the therapeutic approach of cancers. In this review, we also discuss the challenges and prospects for clinical application of exosome-based diagnostics and therapeutics for cancers.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Similar articles

Cited by

References

    1. Jalalian S. H., Ramezani M., Jalalian S. A., Abnous K., Taghdisi S. M. Exosomes, new biomarkers in early cancer detection. Analytical Biochemistry . 2019;571:1–13. doi: 10.1016/j.ab.2019.02.013. - DOI - PubMed
    1. Théry C., Witwer K. W., Aikawa E., et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. Journal of Extracellular Vesicles . 2018;7(1) doi: 10.1080/20013078.2018.1535750.1535750 - DOI - PMC - PubMed
    1. He C., Zheng S., Luo Y., Wang B. Exosome theranostics: biology and translational medicine. Theranostics . 2018;8(1):237–255. doi: 10.7150/thno.21945. - DOI - PMC - PubMed
    1. Yang B., Chen Y., Shi J. Exosome biochemistry and advanced nanotechnology for next-generation theranostic platforms. Advanced Materials . 2019;31(2) doi: 10.1002/adma.201802896.1802896 - DOI - PubMed
    1. Siegel R. L., Miller K. D., Jemal A. Cancer statistics, 2020. CA: A Cancer Journal for Clinicians . 2020;70(1):7–30. doi: 10.3322/caac.21590. - DOI - PubMed

LinkOut - more resources